Reply to “Reconsidering Dopaminergic Modulation in Alzheimer's Disease: A Case for Levodopa/Carbidopa as a Disease-Modifying Agent”
AuthID
P-019-NAH
P-019-NAH
© 2025 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service